工艺装备ES已授权

Combinations comprising benzodioxol as glp-1r agonists for use in the treatment …

Ask AI about this

查看原文 ↗

申请人Pfizer

发明人Gary E Aspnes

公开号ES3039586T3

授权号ES3039586T3

申请日2020-05-15

公开日2025-10-22

授权日2025-10-22

摘要

In part, the invention provides a novel combination comprising (1) a GLP-1 receptor (GLP-1R) agonist and (2) an ACC inhibitor or a DGAT2 inhibitor, or a KHK inhibitor or an FXR receptor agonist. The invention further provides novel methods for treating diseases and disorders, such as fatty liver, …

Combinations comprising benzodioxol as glp-1r agonists for use in the treatment &hellip;

摘要

相关专利

Combinations comprising benzodioxol as glp-1r agonists for use in the treatment …